Skip to main content

Table 2 Serological and molecular findings for HIV and HCV and use of health care services, 2011-14a

From: High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011–14)

 

Berlin

Essen

Leipzig

Frankfurt

Cologne

Hanover

Munich

Hamburg

range

n = 337

n = 197

n = 130

n = 285

n = 322

n = 252

n = 235

n = 319

(min-max)

Serological and molecular findings

n

%

n

%

n

%

n

%

n

%

n

%

n

%

n

%

%

HIV+

13

3.9

12

6.1

0

0

26

9.1

5

1.6

22

8.7

7

3.0

16

5.0

0.0-9.1

HCV seroprevalence; Anti-HCV+ and/or HCV-RNA+

185

54.9

143

72.6

55

42.3

189

66.3

229

71.1

189

75.0

149

63.4

222

69.6

42.3-75.0

Cleared infection; Anti HCV+, HCV RNA-

60

17.8

54

27.4

25

19.2

46

16.1

76

23.6

53

21.0

64

27.2

79

24.8

16.1-27.2

Chronic infection; Anti HCV+, HCV RNA+

121

35.9

86

43.7

23

17.7

138

48.4

138

42.9

131

52.0

83

35.3

137

43.0

17.7-52.0

Seroconverters; Anti HCV-, HCV RNA+

4

1.2

3

1.5

7

5.4

5

1.8

15

4.7

5

2.0

2

0.9

6

1.9

0.9-5.4

Co-infections: Anti HIV+, Anti HCV+ and/or HCV RNA+

12

92.3

12

100.0

-

-

21

80.8

3

60.0

19

86.4

6

85.7

11

68.8

60.0-100.0

Use of health care services and testing history

 Use of harm reduction service (last 30d)

b

-

b

-

b

-

256

90.5

261

81.3

221

87.7

185

78.7

284

89.0

78.7-90.5

 Currently in OST

135

40.3

85

43.2

40

30.8

129

45.3

213

66.2

109

43.3

129

55.1

179

56.3

30.8-66.2

 Ever receiving OST

244

72.8

170

86.3

71

54.6

233

81.8

279

86.7

211

83.7

208

88.9

254

79.6

54.6-88.9

 Ever tested for HIV

298

90.6

184

94.4

98

76.6

277

97.5

302

95.0

233

94.3

220

96.1

301

95.0

76.6-97.5

 Tested for HIV (last 12 m)c

173

57.1

125

68.3

54

43.9

171

66.3

207

69.7

137

60.6

146

69.9

197

68.4

43.9-69.9

 Ever tested for HCV

287

89.4

184

94.9

85

70.3

264

94.6

290

93.6

224

91.8

215

96.0

269

90.0

70.3-96.0

 Tested for HCV (last 12 m)d

70

49.0

39

59.1

21

28.8

44

54.3

60

58.8

30

42.3

52

75.4

47

46.5

28.8-75.4

  1. aFootnote (Table 2): Because not all participants replied to every variable, some variables include missing values. This means that the city-specific denominator for some variables might be lower than the n displayed at the top of the table
  2. bdata not collected
  3. cExcluding those with a diagnosis older than 12 months
  4. dDenominator includes those never tested, those never tested positive and those who had their first HCV diagnosis in the last 12 months